Rhinisaph
Brand Name: Rhinisaph
Generic Name: Cetirizine Dihydrochloride
Active
Registration Number
DRP-10456
Dosage Form
Film-Coated Tablet
Issuance Date
October 1, 2021
Expiry Date
October 1, 2026
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength10 mg
PackagingAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Classification
C
Classification
Over-the-Counter (OTC)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Cetirizine DihydrochlorideActive
Monograph: Cetirizine